Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Lyell Immunopharma, Inc. (LYEL)

14.86 -0.14 (-0.93%)
At close: November 6 at 4:00:01 PM EST
14.86 0.00 (0.00%)
After hours: 7:21:49 PM EST
Trade LYEL on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
15
36
61
130
84,683
Operating Expense
201,220
201,665
220,335
247,138
271,741
Operating Income
-201,205
-201,629
-220,274
-247,008
-187,058
Net Non Operating Interest Income Expense
8,959
13,080
24,068
23,453
7,053
Other Income Expense
-62,914
-85,899
-146,788
-11,077
-3,113
Pretax Income
-255,160
-274,448
-342,994
-234,632
-183,118
Net Income Common Stockholders
-255,160
-274,448
-342,994
-234,632
-183,118
Diluted NI Available to Com Stockholders
-255,160
-274,448
-342,994
-234,632
-183,118
Basic EPS
-12.61
-12.91
-23.26
-18.70
-14.80
Diluted EPS
-12.61
-12.91
-23.26
-18.70
-14.80
Basic Average Shares
22,555.25
21,251.35
14,743.78
12,549
12,354
Diluted Average Shares
22,555.25
21,251.35
14,743.78
12,549
12,354
Total Operating Income as Reported
-267,537
-269,404
-358,755
-247,008
-187,058
Total Expenses
201,220
201,665
220,335
247,138
271,741
Net Income from Continuing & Discontinued Operation
-255,160
-274,448
-342,994
-234,632
-183,118
Normalized Income
-188,828
-206,673
-191,512
-221,709
-178,118
Interest Income
8,959
13,080
24,068
23,453
7,053
Net Interest Income
8,959
13,080
24,068
23,453
7,053
EBIT
-201,205
-201,629
-220,274
-247,008
-187,058
EBITDA
-192,200
-190,090
-200,643
-226,758
-169,038
Reconciled Depreciation
9,005
11,539
19,631
20,250
18,020
Net Income from Continuing Operation Net Minority Interest
-255,160
-274,448
-342,994
-234,632
-183,118
Total Unusual Items Excluding Goodwill
-66,332
-67,775
-151,482
-12,923
-5,000
Total Unusual Items
-66,332
-67,775
-151,482
-12,923
-5,000
Normalized EBITDA
-125,868
-122,315
-49,161
-213,835
-164,038
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 6/17/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: